维普中文期刊产品整合服务
8篇 您的检索式:作者名="Yang Renchi"
    题名 作者 年代 出处 被引量
1Chinese expert consensus on the management of chimeric antigen receptor T cell therapy-associated coagulopathy显示文摘Chimeric antigen receptor T-cell(CAR-T)therapy has greatly improved the disease remission rate and long-term survival rate of patients with relapsed/refractory hematological malignancies.[1-3]Currently,several commercial CAR-T products are available in the market and numerous CAR-T clinical trials have been conducted.Attention should be paid to the safety of CAR-T therapy.The main adverse effects of CAR-T therapy are cytokine release syndrome(CRS)and immune effector cell-associated neurotoxicity syndrome(ICANS).[4]Heng Mei Fangping Chen Yue Han Ming Hou He Huang Xiaojun Huang Yuhua Li Aibin Liang Qifa Liu Ting Niu Jun Peng Wenbin Qian Yongping Song Jianxiang Wang Ying Wang Depei Wu Kailin Xu Linhua Yang Renchi Yang Lei Zhang Liansheng Zhang Xi Zhang Xiaohui Zhang Weili Zhao Weidong Han Yu Hu 2022Chinese Medical Journal2022,,14:4
22021 Chinese consensus on the diagnosis and management of primary immune thrombocytopenia in pregnancy显示文摘Immune thrombocytopenia(ITP)is an acquired disease characterized by isolated thrombocytopenia,which is one of the most common causes of thrombocytopenia during pregnancy.Women with ITP who have severe thrombocytopenia are at an increased risk for life-threatening obstetric complications.Therefore,we established this consensus statement on the diagnosis and management of ITP during pregnancy(detailed information is available in the Supplementary File,http://gffzz16e312a87a7141a5hbpc6ofnp6ppn69uu.ffgz.tsg.suse.edu.cn/A978).Zhang Xiaohui Chen Fangping Chen Xiequn Cheng Yunfeng Fang Meiyun Feng Jianming Fu Haixia Gao Hong Han Yue He Aili Hou Ming Hu Yu Huang Ruibin Huang Wenrong Jing Zhicheng Kong Peiyan Liang Aibin Liang Meiying Liu Daihong Liu Junling Liu Lin Liu Xiaowei Ma Liangming Mei Heng Ni Heyu Niu Ting Peng Jun Qiao Jianlin Ren Jinhai Song Yongping Tang Liang V Tong Tong Wang Shaoyuan Wang Xin Wang Zhao Wei Hui Wu Depei Wu Guangsheng Xu Caigang Xu Xue Xu Yajing Yang Linhua Yang Renchi Yang Tonghua Yin Chenghong Yu Li Zhang Guangsen Zhang Lei Zhang Liansheng Zhang Xi Zhao Weili Zhao Yongqiang Zhou Daobin Zhou Hu Zhou Zeping Zhu Tienan Wang Jianliu Huang Xiaojun 2022Chinese Medical Journal2022,,8:2
3Pathogenesis and management for chronic idiopathic thrombocytopenic purpura:An updae显示文摘YANG Renchi HAN Zhong Chao 1999lnt Hematol1999,,:1
4Pathogenesis and Management for Chronic Thrombocytopenic Purpura: An Update显示文摘 Zhong Chaohan 2000Int J Hematol2000,71,1:1
5Safety and Efficacy ofMoroctocog Alfa (AF-CC) ( XYNTHA) in Minimally Treated andPreviously Treated Chinese Patients with Haemophilia A显示文摘RENCHI YANG YONGQIANG ZHAO 2012Haemo-philia 2012 in-press2012,2012,:1
6Peroxisome proliferator-activated receptor γ in malignant diseases显示文摘Tingting Wang Jian Xu Xiaofei Yu Renchi Yang Zhong Chao Han 2005Critical Reviews in Oncology and Hematology2005,,1:1
7Pathogenesis and management for chronic idiopathic thrombocytopenic purpura:An update显示文摘Renchi Yang Zhongchao Han 2000Int J Hematol2000,,1:1
8Pathogenesis and Management for Chronic Idiopathic Thrombocytopenic Purpura: An Update显示文摘 HAN Zhongchao 1999Int J Hematol1999,,:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费